A new study reveals that only about 1 in 3 patients with prostate cancer have a successful first CT simulation, while 1 in 6 need to be rescheduled for another day.

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

For many men with prostate cancer, weeks of daily treatments are no longer the norm. Jonathan Tward, MD, a radiation oncologist at Huntsman Cancer Institute, explains how image guidance, real-time ...

GRAND RAPIDS, Mich. — 3.3 million American men live with prostate cancer, according to Zero Prostate Cancer. That makes it the most commonly diagnosed cancer for men in the U.S. There is a fairly new ...

If you or a loved one has been diagnosed with prostate cancer, you’re not alone—and you don’t have to wait long to take the next step. Whether you’re newly diagnosed, moving from active surveillance ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

Among patients with prostate cancer who received MRI-guided stereotactic body radiation therapy (SABR), more than 80% demonstrated “classic” neurovascular bundle patterns and over 96% showed more than ...

Two Atlanta-area prostate cancer survivors are joining forces to share their stories in an effort to help others. Ernie ...

Dr. Kalnicki answers the question: 'Is Prostate Surgery Done After Radiation?' March 16, 2009 -- Question: Can I have prostate surgery if my radiation treatments are unsuccessful? Answer: Prostate ...

Radiation-related bowel toxicity among real-world patients was lower with use of the rectal spacer. Use of a hydrogel rectal spacer reduces the incidence of bowel disorders and related procedures over ...

A new treatment strategy tested by UCLA researchers could offer new hope for men whose prostate cancer has returned after initial treatment. This approach could also help delay the need for hormone ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.